Peter Toth
5 Papers
7 Citations
Peter Toth is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Protamine reversal of low molecular weight heparin: clinically effective?
Joost J. van Veen,Rhona Maclean,K. K. Hampton,Stuart Laidlaw,Steve Kitchen,Peter Toth,Michael Makris +6 more
TL;DR: Low molecular weight heparins are frequently used in the prophylaxis or treatment of venous thrombosis, acute coronary syndromes and peri-operative bridging and better reversal agents and methods to monitor LMWH therapy are required.
80
Prothrombin complex concentrate-related thrombotic risk following anticoagulation reversal
Peter Toth,Michael Makris +1 more
TL;DR: Concern is with the enormous variability in the studies included, especially with respect to: a) the proportion of patients receiving PCC for emergency reversal of bleeding versus surgery, and b) the differences in starting INR, dose and type of PCC used.
7
Fecal calprotectin levels in pediatric cow's milk protein allergy
Dominika Lendvai-Emmert,V. Emmert,Alexandra Makai,K. Fusz,Viktória Prémusz,Kata Eklics,Patrícia Sarlós,Peter Toth,Krisztina Amrein,Gergely Tóth +9 more
TL;DR: The findings of this study suggest that FC can be an objective marker in confirming the diagnosis of CMPA and significant improvement in clinical symptoms and in FC levels can only be expected after a strictly followed elimination diet.
A Randomized Study to Evaluate the Effect of an Inclisiran First Implementation Strategy vs Usual Care in Patients with ASCVD and Elevated Low-density Lipoprotein Cholesterol: Rationale and Design of the VICTORION-INITIATE Trial
Cara East,Fatima Rodriguez,Robert M. Stoekenbroek,Dion H. Zappe,Peter Toth,Jennifer Robinson,Michael J. Koren +6 more
TL;DR: The Conquer-Initiate trial as mentioned in this paper evaluated the efficacy of an inclisiran first strategy vs usual care to treat atherosclerotic cardiovascular disease (ASCVD) with statin therapy.
1
Real world usage of PCC to "rapidly" correct warfarin induced coagulopathy.
Peter Toth,Joost J. van Veen,Kate Robinson,Rhona Maclean,K. K. Hampton,Stuart Laidlaw,Michael Makris +6 more
TL;DR: The local protocol for reversal with PCC and vitamin K was adhered to well but the delay in pre-procedural patients, suggests that intravenous vitamin K alone may be sufficient in many cases and PCC administration can be avoided by better planning.